Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of two nab-paclitaxel monotherapy doses in previously treated advanced non-small cell lung cancer
jRCTs031180214Phase 2Completed
- Sponsor
- Japan Multinational Trial Organization
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Japan Multinational Trial Organization. Primary endpoint: Progression-free survival. Started May 2015; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs031180214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180214.